<DOC>
	<DOCNO>NCT00823472</DOCNO>
	<brief_summary>Background study : Milder stimulation protocols advantage less expensive patient-friendly . Moreover , recent evidence suggest mild stimulation protocol lead low embryo aneuploidy rate compare conventional treatment regimen . Although mild stimulation protocol expect number oocyte retrieve low , pregnancy rate show similar possibly embryo quality outfavours embryo quantity . Objective study : The aim study determine whether cycle day ( CD ) 5 start stimulation lead well quality embryo , base morphology , CD 2 start , IVF GnRH antagonist co-treatment start fixed day . Study design : Prospective randomize trial compare two different start day ovarium stimulation ( day 2 versus day 5 ) IVF treatment . Intervention : One group wil start cycle day 2 stimulation ovary recombinant FSH . The group start cycle day 5 . Both group start suppress gonadotrophin production pituitary gland cycle day 6 GnRH antagonist . Primary study parameters/outcome study : Primary outcome parameter number top embryo per ovum pick . Secondary study parameters/outcome study : Secondary outcome measure duration stimulation , cancellation rate , fertilization rate , number cumulus oocyte complex obtain , number mature oocyte obtain , number top embryo per start cycle , amount IU recFSH , clinical pregnancy rate .</brief_summary>
	<brief_title>Trial Comparing Start Stimulation Recombinant Follicle Stimulating Hormone ( rFSH ) Cycle Day 2 Versus Cycle Day 5 In Vitro Fertilization ( IVF )</brief_title>
	<detailed_description />
	<mesh_term>Follicle Stimulating Hormone</mesh_term>
	<criteria>Female age &lt; 36 year FSH &lt; 12 IU/l BMI 1829 kg/m2 Regular cycle ( 2535 day ) No major uterine ovarian abnormalities No previous IVF cycle Written inform consent Oocyte donation Medical contra indication pregnancy IVF treatment Endometriosis â‰¥ grade 3 Polycystic Ovarium Syndrome ( PCOS ) Endocrine metabolic abnormality ( pituitary , adrenal , pancreas , liver kidney )</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>36 Years</maximum_age>
	<verification_date>January 2009</verification_date>
	<keyword>embryonic structure</keyword>
	<keyword>sperm injection , intracytoplasmic</keyword>
	<keyword>IVF</keyword>
	<keyword>GnRH antagonist</keyword>
	<keyword>ovarian stimulation</keyword>
	<keyword>cycle day 2 versus cycle day 5</keyword>
</DOC>